EXCLUSIVE ONLINE CONTENT

2/7/2019

uniQure Announces First Patient Treated in Pivotal Trial

uniQure N.V. recently announced it treated the first patient in its HOPE-B pivotal trial of AMT-061, an investigational AAV5-based gene therapy incorporating the patent-protected FIX-Padua variant for the treatment of patients with severe and moderately severe hemophilia B.

2/7/2019

Meridian Launches New Range of Lyo-Ready PCR Mixes

Meridian Bioscience, Inc. recently announced that following the successful release of the Lyo-Ready qPCR Mix, Meridian is proud to introduce its next-generation lyophilization-ready mixes for one-step RT-qPCR.

2/1/2019

AbbVie’s Immunology Pipeline Will Protect it From Biosimilar Erosion

Although AbbVie is feeling the impact of Humira biosimilar launch in Europe, its strong immunology pipeline is likely to protect its hold on the plaque psoriasis (PsO) and rheumatoid arthritis (RA) markets, according to GlobalData, a leading data and analytics company.